Thread by @SputnikInt

🚨🇷🇺💉Russia's cancer vaccine — the world's FIRST — could begin reaching patients within A FEW months.

 Here's why experts are calling it revolutionary:🧵

💥 IMMUNE MARKSMAN 

The breakthrough drug “trains” the immune system to recognize and destroy tumor-specific antigens — helping eliminate remaining cancer cells and prevent metastasis or recurrence.

Think of it as your immune system’s private sniper team.

2/8

🫡 TOTAL PERSONALIZATION 

The vaccine is fully personalized, based on a patient’s own tumor’s genetic data.

Doctors extract a sample of the tumor → decode its antigens → create a tailored mRNA shot to target exactly those cells.
3/8

🔥 MULTIPURPOSE MATTERS 

The project focuses first on melanoma patients, due to the cancer’s high immunogenicity (response to immune treatment).

But trials could soon expand to other cancers — breast, lung, pancreatic, and more.
4/8

💥 AI-BACKED 

And it’s fast: 

AI analyzes each tumor and generates a custom “blueprint” — allowing specialists to produce a personalized vaccine in just about a week.
5/8

😍 BUILT BY TOP SCIENCE TEAMS

Developed by the Gamaleya Institute of Epidemiology & Microbiology (creators of Sputnik V) in cooperation with Russia’s leading oncology institutions:

▪️ Hertsen Research Institute

▪️ Blokhin Cancer Center
6/8

🔥 PROMISING EARLY RESULTS

In mice with melanoma, trials showed strong antitumor effects, according to Gamaleya’s director, Alexander Gintsburg.
7/8

😎 WORLD AWAITS 

If successful in human trials, this could be a game-changer for global oncology — shifting treatment from one-size-fits-all to bespoke immune precision strikes.
8/8